Table 2.

Demographic and clinicopathologic characteristics of 38 study subjects who underwent radical prostatectomy

	Cancer
	N = 38
Median Age (range, y)	63 (47-72)
Race
White	24 (63)
African American	12 (32)
Other	2 (5)
Median Serum PSA (ng/ml)	9.2 ± 4.7
Pathologic Stage
pT2	31 (82%)
pT3a	3 (8%)
pT3b	4 (10%)
N0	36 (95%)
N1	2 (5%)
Gleason Score
6	19 (50%)
7	13 (34%)
>7	6 (16%)